Síndrome antifosfolípido (SAF): diferencias clínicas e inmunoserológicas entre SAF primario y secundario en una cohorte colombiana

Schreiber, 2016, Antiphospholipid antibodies and syndrome: complexities in diagnosis and management, 485 Jameson J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J. Harrison's principles of internal medicine, 20 ed. Nueva York, NY: McGraw-Hill [Internet] [consultado 25 Oct 2018]. Disponible en: http://accessmedicine.mhmedical.com.bdigital.ces.edu.co:2048/content.aspx?bookid=2129&sectionid=192284956 Unlu, 2019, The impact of systemic lupus erythematosus on the clinical phenotype of antiphospholipid antibody-positive patients: results from the antiphospholipid syndrome alliance for clinical trials and international clinical database and repository, Arthritis Care Res (Hoboken)., 71, 134, 10.1002/acr.23584 Giannakopoulos, 2013, The pathogenesis of the antiphospholipid syndrome, N Engl J Med., 368, 1033, 10.1056/NEJMra1112830 Chaturvedi, 2017, Diagnosis and management of the antiphospholipid syndrome, Blood Rev., 31, 406, 10.1016/j.blre.2017.07.006 Vargas, 2006, Síndrome antifosfolípido: mortalidad y evolución de una cohorte de pacientes del Hospital Pablo Tobón Uribe de Medellín-Colombia, Rev Colomb Reumatol., 13, 109 Mesa, 2012, Antiphospholipid syndrome: description of a cohort from Colombia and evaluation of thrombosis risk factors, Rev Colomb Reumatol [Internet]. Osio, 2010, Síndrome antifosfolipídico: descripción de una cohorte de 32 pacientes del suroccidente colombiano, Rev Colomb Reumatol., 17, 172 Cervera, 2002, Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients, Arthritis Rheum., 46, 1019, 10.1002/art.10187 Petri, 2000, Epidemiology of the antiphospholipid antibody syndrome antibodies in normals methodological issues, J Autoimmun., 15, 145, 10.1006/jaut.2000.0409 Cervera, 2017, Antiphospholipid syndrome, Thromb Res., 151, S43, 10.1016/S0049-3848(17)30066-X Alijotas-Reig, 2015, The European Registry on Obstetric Antiphospholipid Syndrome (Euroaps): a survey of 247 consecutive cases, Autoimmun Rev., 14, 387, 10.1016/j.autrev.2014.12.010 Silver, 2013, Antiphospholipid antibodies in stillbirth, Obstet Gynecol., 122, 641, 10.1097/AOG.0b013e3182a1060e Carvalho, 2011, Influence of gender on the clinical and laboratory spectra of patients with primary antiphospholipid syndrome, Rheumatol Int., 31, 647, 10.1007/s00296-009-1346-0 Dufrost, 2016, Direct oral anticoagulants use in antiphospholipid syndrome: are these drugs an effective and safe alternative to warfarin? A systematic review of the literature, Curr Rheumatol Rep., 18, 74, 10.1007/s11926-016-0623-7 Cohen, 2016, Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial, Lancet Haematol., 3, e426, 10.1016/S2352-3026(16)30079-5 Pengo, 2018, Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome, Blood., 132, 1365, 10.1182/blood-2018-04-848333 Ordi-Ros, 2019, Rivaroxaban versus vitamin K antagonist in antiphospholipid syndrome: a randomized noninferiority trial, Ann Intern Med., 171, 685, 10.7326/M19-0291